Upgrade to SI Premium - Free Trial

Galapagos NV (GLPG)

27.73 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26 *Est.)

Latest Headlines

Form 6-K Lakefront Biotherapeutic For: Jul 28 July 28, 2026 4:22 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jul 21 July 21, 2026 4:29 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jul 14 July 15, 2026 6:17 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jul 13 July 13, 2026 4:33 PM - SEC Filing Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi July 13, 2026 4:01 PM - Globe NewsWire Form 6-K Lakefront Biotherapeutic For: Jul 07 July 7, 2026 4:25 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 30 June 30, 2026 4:37 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 29 June 30, 2026 6:02 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 23 June 24, 2026 6:05 AM - SEC Filing Form SCHEDULE 13G Lakefront Biotherapeutic Filed by: Madison Avenue Partners, LP June 23, 2026 6:50 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 16 June 16, 2026 4:27 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 09 June 9, 2026 4:55 PM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 08 June 9, 2026 6:11 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: Jun 04 June 5, 2026 6:06 AM - SEC Filing Form 6-K Lakefront Biotherapeutic For: May 26 May 27, 2026 6:04 AM - SEC Filing Form 424B3 Lakefront Biotherapeutic May 8, 2026 4:21 PM - SEC Filing Galapagos NV (GLPG) Tops Q1 EPS by 115c May 6, 2026 6:04 PM - StreetInsider Form 6-K GALAPAGOS NV For: May 06 May 6, 2026 5:19 PM - SEC Filing Full Article List